Bionano Genomics BNGO Institutional Ownership

Updated Oct 10, 2026

Bionano Genomics, Inc. (NASDAQ:BNGO) had 34 institutional holders reporting a position on Form 13F for the quarter ended June 30, 2026.

• Their combined stake equaled 6.02% of outstanding shares in Q2 2026, down from 7.72% in Q1 2026.
• Total holdings of Bionano Genomics shares fell 18.52% from Q1 2026, and the number of holders rose 25.93% from Q2 2025.
• Of the 34 holders of BNGO in Q2 2026, 20 added to their positions, 2 reduced their stakes and 12 left their positions unchanged.
• The aggregate institutional position in Bionano Genomics was 709.45K shares at the end of Q2 2026, down 161.23K from the prior quarter and up 620.65K from a year earlier.
• GSA Capital Partners LLP led 13F holders of BNGO with 150.28K shares as of June 30, 2026, or 1.28% of shares outstanding.
• Holders that added the most shares of Bionano Genomics in Q2 2026 were Carret Asset Management, LLC (+55K shares), Vanguard Capital Management LLC (+14.28K shares), Northern Trust Corp (+4.04K shares), Prudential Financial Inc (+3.6K shares) and Renaissance Technologies LLC (+2.4K shares).
• The largest position reductions in BNGO for Q2 2026 were by GSA Capital Partners LLP (-203.08K shares) and Geode Capital Management, LLC (-77.54K shares).
• Per Business Quant data, the 10 largest holders of Bionano Genomics at the end of Q2 2026 were GSA Capital Partners LLP (150.28K shares), Carret Asset Management, LLC (125K shares), Geode Capital Management, LLC (89.99K shares), Vanguard Capital Management LLC (82.39K shares), Vanguard Fiduciary Trust Co (51.58K shares), Renaissance Technologies LLC (51.1K shares), Jane Street Group, LLC (35.73K shares), Prudential Financial Inc (31.6K shares), Northern Trust Corp (24.56K shares) and XTX Topco Ltd (16.3K shares).